Skip to main content
. 2018 Apr 16;98(5):290–301. doi: 10.1093/ptj/pzy021

Table 2.

Descriptive Baseline Characteristics of Study Participants With and Those Without Persistent Musculoskeletal Pain at 12 Monthsa.

Variable Total Sample (n = 279) Participants With Persistent Pain (n = 101) Participants Without Persistent Pain (n = 178) P
Demographic
Age, y, mean (SD) 46.5 (S) 48.3 (15.1) 45.4 (16.5) .152
Sex, women 183 (65.6) 73 (72.3) 110 (61.8) .173
Race .276
American Indian/Alaska native 2 (0.7) 1 (1.0) 1 (0.6)
Asian 17 (6.1) 2 (2.0) 15 (8.4)
Black or African American 30 (10.8) 11 (10.9) 19 (10.7)
White 226 (81.0) 86 (85.1) 140 (78.7)
Prefer not to answer 4 (1.4) 1 (1.0) 3 (1.7)
Household income .004
<Inline graphic20,000 30 (10.8) 20 (19.8) 10 (5.6)
Inline graphic20,000–Inline graphic35,000 39 (14.0) 16 (15.8) 23 (12.9)
Inline graphic35,001–Inline graphic50,000 33 (11.8) 8 (7.9) 25 (14.0)
Inline graphic50,001–Inline graphic70,000 32 (11.5) 12 (11.9) 20 (11.2)
>Inline graphic70,000 112 (40.1) 32 (31.7) 80 (44.9)
Prefer not to answer 33 (11.8) 13 (12.9) 20 (11.2)
Employment .055
Employed full-time 149 (53.4) 48 (47.5) 101 (56.7)
Employed part-time 41 (14.7) 10 (9.9) 31 (17.4)
Unemployed 30 (10.8) 15 (14.9) 15 (8.4)
Retired 47 (16.8) 22 (21.8) 25 (14.0)
Prefer not to answer 12 (4.3) 6 (5.9) 6 (3.4)
Education .208
High school or lower 18 (6.5) 6 (5.9) 12 (6.7)
Some college 63 (22.6) 29 (28.7) 34 (19.1)
Graduated from college 79 (28.3) 32 (31.7) 47 (26.4)
Some postgraduate course work 41 (14.7) 14 (13.9) 27 (15.2)
Completed postgraduate degree 74 (26.5) 19 (18.8) 55 (30.9)
Prefer not to answer 4 (1.4) 1 (1.0) 3 (1.7)
Geographical region .095
Portland, OR 16 (5.7) 4 (4.0) 12 (6.7)
Los Angeles, CA 43 (15.4) 10 (9.9) 33 (18.5)
Greenville, SC 58 (20.8) 24 (23.8) 34 (19.1)
Boulder, CO 16 (5.7) 6 (5.9) 10 (5.6)
Jacksonville, FL 29 (10.4) 9 (8.9) 20 (11.2)
Gainesville, FL 80 (28.7) 37 (36.6) 43 (24.2)
Philadelphia, PA 13 (4.7) 1 (1.0) 12 (6.7)
Chicago, IL 11 (3.9) 5 (5.0) 6 (3.4)
Terra Haute, IN 13 (4.7) 5 (5.0) 8 (4.5)
Clinical
Body region .403
Neck 59 (21.1) 23 (22.8) 36 (20.2)
Low back 72 (25.8) 31 (30.7) 41 (23.0)
Shoulder 66 (23.7) 21 (20.8) 45 (25.3)
Knee 82 (29.4) 26 (25.7) 56 (31.5)
Surgery, yes 46 (16.5) 16 (15.8) 30 (16.9) .827
Persistent pain at baseline, yes 222 (79.6) 84 (83.2) 138 (77.5) .261
Episodes over past year, yes 143 (51.3) 62 (61.4) 81 (45.5) .036
Pain intensity, NPRS, mean (SD) 3.9 (1.7) 4.7 (1.5) 3.4 (1.6) <.0001
Comorbidityb <.0001
0 79 (28.3) 17 (16.8) 62 (34.8)
1 54 (19.4) 14 (13.9) 40 (22.5)
≥2 144 (51.6) 70 (69.3) 74 (41.6)
OSPRO-ROS, 10 items, mean (SD) 2.6 (2.3) 3.4 (2.7) 2.1 (1.9) <.0001
OSPRO-ROS + additional 13 items,c mean (SD) 1.2 (1.6) 1.8 (1.9) 0.8 (1.2) <.0001
OSPRO-YF, 10 items, mean (SD) 16.9 (6.3) 19.4 (7.1) 15.5 (5.3) <.0001
OSPRO-YF + additional 7 items,c mean (SD) 14.3 (4.9) 16.0 (5.3) 13.4 (4.4) <.0001

aData are reported as number (percentage) of participants unless otherwise indicated. NPRS = numerical pain rating scale (potential range = 0–10, with higher scores indicating higher pain intensity), OSPRO-ROS = Optimal Screening for Prediction of Referral and Outcome Review of Systems; OSPRO-YF = Optimal Screening for Prediction of Referral and Outcome Yellow Flag.

bComorbidity data included composite counts (0, 1, or ≥2) from the Charlson Comorbidity Index and the Functional Comorbidity Index.

cAdditional items were from longer versions of the corresponding tool.